The company currently has 28 authorized invention patents,and more than 170 invention patents have been submitted for application and are in various stages of examination;A number of other patents are pending.
Innovative Drug development:
The research and development of 16 innovative drugs for cardio-cerebrovascular,respiratory,renal and antifungal systems has been carried out.
1 project is in phase II clinical development;Three projects are in phase I clinical development;Five projects are being prepared for IND.
More than 170 invention patents have been applied for or authorized,including 36 PCT patents;
Generic Drug development:
13 projects under research;
Obtained 9 production approvals and 7 new drug certificates;
176 registered trademarks.
©2023 Wuhan RS Pharmaceuticals Co., Ltd
Powered by:300.cn | IPV6 access is supported